1. Inhalt
  2. Navigation
  3. Weitere Inhalte
  4. Metanavigation
  5. Suche
  6. Choose from 30 Languages

Business

Bayer Books Profit in 2004

The German pharmaceutical and chemicals giant Bayer has returned to profits in 2004 after experiencing a bottom-line loss of €1.361 billion ($1.78 billion) in 2003. On Wednesday, the aspirin maker reported a net profit for 2004 of €603 million. Underlying earnings for 2004 also improved, with operating profit before special items rising by 53.1 percent to €2.244 billion, Bayer said in a statement. According to chairman Werner Wenning, the improvement in earnings was attributable to "a marked upturn in business," as well as cost-cutting and efficiency-boosting measures. "We were therefore able to more than offset the sharp rise in raw materials prices, negative currency effects and the expiration of the US patent" for the wide-spectrum anti-biotic Cipro, he said. Bayer shareholders can look forward to an increase in the dividend payout to €0.55 per share for 2004 from €0.50 for 2003 after the positive results.

DW recommends